
DocGo (DCGO) Stock Forecast & Price Target
DocGo (DCGO) Analyst Ratings
Bulls say
DocGo Inc. demonstrates a strong positive outlook due to its projected growth in the hospital segment, which is expected to increase from approximately $200 million in 2024 to $250 million in 2025, primarily driven by advancements in medical transportation and mobile health services. The company's robust logistics platform has resulted in high customer renewal rates and expansion opportunities, particularly with new client acquisition in growing markets like Texas, indicating significant potential for revenue diversification and enhancement. Furthermore, as DocGo shifts resources toward its payor business, management remains optimistic about meeting payor targets and enhancing revenues through care gap visits and preventative care programs, positioning the company favorably for long-term growth in value-based care arrangements.
Bears say
DocGo Inc. has experienced a significant decline in its financial performance, primarily due to disappointing revenue from its Mobile Health Services segment, which fell 52.3% year-over-year and came in 9.9% below estimates. The company has revised its adjusted EBITDA margin expectations downward to approximately 5%, reflecting increased operational expenses associated with transitioning away from migrant-related work and investments in its care gap closure program. The combination of lower-than-expected revenue and operational challenges has resulted in adjusted EBITDA of just $1.1 million, markedly below the estimated $13.4 million, indicating financial instability and a challenging outlook for the company's growth prospects.
This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.
DocGo (DCGO) Analyst Forecast & Price Prediction
Start investing in DocGo (DCGO)
Order type
Buy in
Order amount
Est. shares
0 shares